Trump’s ‘Buy American’ order raises doubts – STAT
FDA Commissioner Stephen Hahn insisted any Covid-19 approval would “adhere to standards,” but he left the door open to emergency use authorization.
FDA Commissioner Stephen Hahn insisted any Covid-19 approval would “adhere to standards,” but he left the door open to emergency use authorization.
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
The authors of a new study argue the heralded arrival of biosimilars failed to fully deliver on their promise.
“Colombia is planting a flag for global health equity,” said Peter Maybarduk, who heads the access to medicines campaign at Public Citizen.
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they’re set to cost the U.S. health care system and the federal government…
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth’s OptumRx unit will not be renewed after they expire in June.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Biocon is developing a generic version of Novo Nordisk’s Wegovy and is prepared to conduct a clinical trial next year if needed.